Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Decitabine Market Growth 2022-2028

  • LP 4832627
  • 119 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Decitabine will have significant change from previous year. According to our (LP Information) latest study, the global Decitabine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Decitabine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Decitabine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Decitabine market, reaching US$ million by the year 2028. As for the Europe Decitabine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Decitabine players cover Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., and Otsuka Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Decitabine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

10 Mg Dosage Forms

15 Mg Dosage Forms

25 Mg Dosage Forms

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Primary MDS

Secondary MDS

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Johnson & Johnson

Eli Lilly and Company

Pharmachemie B.V.

Otsuka Pharmaceutical

Sandoz

Dr Reddy's Laboratories

Accord Healthcare

Sun Pharmaceutical

Cipla

Lupin

Shandong Xinshidai Pharmaceutical

Hangzhou Zhongmei Huadong Pharmaceutical

ZHENGDA Tianqing Pharmaceutical Group

Jiangsu Aosaikang Pharmaceutical

Jiangsu Haosen Pharmaceutical Group

Lianyungang Jierui Pharmaceutical

Qilu Pharmaceutical Hainan

Lianyungang Runzhong Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Decitabine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Decitabine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Decitabine by Country/Region, 2017, 2022 & 2028

2.2 Decitabine Segment by Type

2.2.1 10 Mg Dosage Forms

2.2.2 15 Mg Dosage Forms

2.2.3 25 Mg Dosage Forms

2.3 Decitabine Sales by Type

2.3.1 Global Decitabine Sales Market Share by Type (2017-2022)

2.3.2 Global Decitabine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Decitabine Sale Price by Type (2017-2022)

2.4 Decitabine Segment by Application

2.4.1 Primary MDS

2.4.2 Secondary MDS

2.5 Decitabine Sales by Application

2.5.1 Global Decitabine Sale Market Share by Application (2017-2022)

2.5.2 Global Decitabine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Decitabine Sale Price by Application (2017-2022)

3 Global Decitabine by Company

3.1 Global Decitabine Breakdown Data by Company

3.1.1 Global Decitabine Annual Sales by Company (2020-2022)

3.1.2 Global Decitabine Sales Market Share by Company (2020-2022)

3.2 Global Decitabine Annual Revenue by Company (2020-2022)

3.2.1 Global Decitabine Revenue by Company (2020-2022)

3.2.2 Global Decitabine Revenue Market Share by Company (2020-2022)

3.3 Global Decitabine Sale Price by Company

3.4 Key Manufacturers Decitabine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Decitabine Product Location Distribution

3.4.2 Players Decitabine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Decitabine by Geographic Region

4.1 World Historic Decitabine Market Size by Geographic Region (2017-2022)

4.1.1 Global Decitabine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Decitabine Annual Revenue by Geographic Region

4.2 World Historic Decitabine Market Size by Country/Region (2017-2022)

4.2.1 Global Decitabine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Decitabine Annual Revenue by Country/Region

4.3 Americas Decitabine Sales Growth

4.4 APAC Decitabine Sales Growth

4.5 Europe Decitabine Sales Growth

4.6 Middle East & Africa Decitabine Sales Growth

5 Americas

5.1 Americas Decitabine Sales by Country

5.1.1 Americas Decitabine Sales by Country (2017-2022)

5.1.2 Americas Decitabine Revenue by Country (2017-2022)

5.2 Americas Decitabine Sales by Type

5.3 Americas Decitabine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Decitabine Sales by Region

6.1.1 APAC Decitabine Sales by Region (2017-2022)

6.1.2 APAC Decitabine Revenue by Region (2017-2022)

6.2 APAC Decitabine Sales by Type

6.3 APAC Decitabine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Decitabine by Country

7.1.1 Europe Decitabine Sales by Country (2017-2022)

7.1.2 Europe Decitabine Revenue by Country (2017-2022)

7.2 Europe Decitabine Sales by Type

7.3 Europe Decitabine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Decitabine by Country

8.1.1 Middle East & Africa Decitabine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Decitabine Revenue by Country (2017-2022)

8.2 Middle East & Africa Decitabine Sales by Type

8.3 Middle East & Africa Decitabine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Decitabine

10.3 Manufacturing Process Analysis of Decitabine

10.4 Industry Chain Structure of Decitabine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Decitabine Distributors

11.3 Decitabine Customer

12 World Forecast Review for Decitabine by Geographic Region

12.1 Global Decitabine Market Size Forecast by Region

12.1.1 Global Decitabine Forecast by Region (2023-2028)

12.1.2 Global Decitabine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Decitabine Forecast by Type

12.7 Global Decitabine Forecast by Application

13 Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Johnson & Johnson Company Information

13.1.2 Johnson & Johnson Decitabine Product Offered

13.1.3 Johnson & Johnson Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson & Johnson Main Business Overview

13.1.5 Johnson & Johnson Latest Developments

13.2 Eli Lilly and Company

13.2.1 Eli Lilly and Company Company Information

13.2.2 Eli Lilly and Company Decitabine Product Offered

13.2.3 Eli Lilly and Company Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly and Company Main Business Overview

13.2.5 Eli Lilly and Company Latest Developments

13.3 Pharmachemie B.V.

13.3.1 Pharmachemie B.V. Company Information

13.3.2 Pharmachemie B.V. Decitabine Product Offered

13.3.3 Pharmachemie B.V. Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pharmachemie B.V. Main Business Overview

13.3.5 Pharmachemie B.V. Latest Developments

13.4 Otsuka Pharmaceutical

13.4.1 Otsuka Pharmaceutical Company Information

13.4.2 Otsuka Pharmaceutical Decitabine Product Offered

13.4.3 Otsuka Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Otsuka Pharmaceutical Main Business Overview

13.4.5 Otsuka Pharmaceutical Latest Developments

13.5 Sandoz

13.5.1 Sandoz Company Information

13.5.2 Sandoz Decitabine Product Offered

13.5.3 Sandoz Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sandoz Main Business Overview

13.5.5 Sandoz Latest Developments

13.6 Dr Reddy's Laboratories

13.6.1 Dr Reddy's Laboratories Company Information

13.6.2 Dr Reddy's Laboratories Decitabine Product Offered

13.6.3 Dr Reddy's Laboratories Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dr Reddy's Laboratories Main Business Overview

13.6.5 Dr Reddy's Laboratories Latest Developments

13.7 Accord Healthcare

13.7.1 Accord Healthcare Company Information

13.7.2 Accord Healthcare Decitabine Product Offered

13.7.3 Accord Healthcare Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Accord Healthcare Main Business Overview

13.7.5 Accord Healthcare Latest Developments

13.8 Sun Pharmaceutical

13.8.1 Sun Pharmaceutical Company Information

13.8.2 Sun Pharmaceutical Decitabine Product Offered

13.8.3 Sun Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sun Pharmaceutical Main Business Overview

13.8.5 Sun Pharmaceutical Latest Developments

13.9 Cipla

13.9.1 Cipla Company Information

13.9.2 Cipla Decitabine Product Offered

13.9.3 Cipla Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Cipla Main Business Overview

13.9.5 Cipla Latest Developments

13.10 Lupin

13.10.1 Lupin Company Information

13.10.2 Lupin Decitabine Product Offered

13.10.3 Lupin Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Lupin Main Business Overview

13.10.5 Lupin Latest Developments

13.11 Shandong Xinshidai Pharmaceutical

13.11.1 Shandong Xinshidai Pharmaceutical Company Information

13.11.2 Shandong Xinshidai Pharmaceutical Decitabine Product Offered

13.11.3 Shandong Xinshidai Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shandong Xinshidai Pharmaceutical Main Business Overview

13.11.5 Shandong Xinshidai Pharmaceutical Latest Developments

13.12 Hangzhou Zhongmei Huadong Pharmaceutical

13.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information

13.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Offered

13.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview

13.12.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments

13.13 ZHENGDA Tianqing Pharmaceutical Group

13.13.1 ZHENGDA Tianqing Pharmaceutical Group Company Information

13.13.2 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Offered

13.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 ZHENGDA Tianqing Pharmaceutical Group Main Business Overview

13.13.5 ZHENGDA Tianqing Pharmaceutical Group Latest Developments

13.14 Jiangsu Aosaikang Pharmaceutical

13.14.1 Jiangsu Aosaikang Pharmaceutical Company Information

13.14.2 Jiangsu Aosaikang Pharmaceutical Decitabine Product Offered

13.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview

13.14.5 Jiangsu Aosaikang Pharmaceutical Latest Developments

13.15 Jiangsu Haosen Pharmaceutical Group

13.15.1 Jiangsu Haosen Pharmaceutical Group Company Information

13.15.2 Jiangsu Haosen Pharmaceutical Group Decitabine Product Offered

13.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Jiangsu Haosen Pharmaceutical Group Main Business Overview

13.15.5 Jiangsu Haosen Pharmaceutical Group Latest Developments

13.16 Lianyungang Jierui Pharmaceutical

13.16.1 Lianyungang Jierui Pharmaceutical Company Information

13.16.2 Lianyungang Jierui Pharmaceutical Decitabine Product Offered

13.16.3 Lianyungang Jierui Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Lianyungang Jierui Pharmaceutical Main Business Overview

13.16.5 Lianyungang Jierui Pharmaceutical Latest Developments

13.17 Qilu Pharmaceutical Hainan

13.17.1 Qilu Pharmaceutical Hainan Company Information

13.17.2 Qilu Pharmaceutical Hainan Decitabine Product Offered

13.17.3 Qilu Pharmaceutical Hainan Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Qilu Pharmaceutical Hainan Main Business Overview

13.17.5 Qilu Pharmaceutical Hainan Latest Developments

13.18 Lianyungang Runzhong Pharmaceutical

13.18.1 Lianyungang Runzhong Pharmaceutical Company Information

13.18.2 Lianyungang Runzhong Pharmaceutical Decitabine Product Offered

13.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Lianyungang Runzhong Pharmaceutical Main Business Overview

13.18.5 Lianyungang Runzhong Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Decitabine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Decitabine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 10 Mg Dosage Forms

Table 4. Major Players of 15 Mg Dosage Forms

Table 5. Major Players of 25 Mg Dosage Forms

Table 6. Global Decitabine Sales by Type (2017-2022) & (K Units)

Table 7. Global Decitabine Sales Market Share by Type (2017-2022)

Table 8. Global Decitabine Revenue by Type (2017-2022) & ($ million)

Table 9. Global Decitabine Revenue Market Share by Type (2017-2022)

Table 10. Global Decitabine Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Decitabine Sales by Application (2017-2022) & (K Units)

Table 12. Global Decitabine Sales Market Share by Application (2017-2022)

Table 13. Global Decitabine Revenue by Application (2017-2022)

Table 14. Global Decitabine Revenue Market Share by Application (2017-2022)

Table 15. Global Decitabine Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Decitabine Sales by Company (2020-2022) & (K Units)

Table 17. Global Decitabine Sales Market Share by Company (2020-2022)

Table 18. Global Decitabine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Decitabine Revenue Market Share by Company (2020-2022)

Table 20. Global Decitabine Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Decitabine Producing Area Distribution and Sales Area

Table 22. Players Decitabine Products Offered

Table 23. Decitabine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Decitabine Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Decitabine Sales Market Share Geographic Region (2017-2022)

Table 28. Global Decitabine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Decitabine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Decitabine Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Decitabine Sales Market Share by Country/Region (2017-2022)

Table 32. Global Decitabine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Decitabine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Decitabine Sales by Country (2017-2022) & (K Units)

Table 35. Americas Decitabine Sales Market Share by Country (2017-2022)

Table 36. Americas Decitabine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Decitabine Revenue Market Share by Country (2017-2022)

Table 38. Americas Decitabine Sales by Type (2017-2022) & (K Units)

Table 39. Americas Decitabine Sales Market Share by Type (2017-2022)

Table 40. Americas Decitabine Sales by Application (2017-2022) & (K Units)

Table 41. Americas Decitabine Sales Market Share by Application (2017-2022)

Table 42. APAC Decitabine Sales by Region (2017-2022) & (K Units)

Table 43. APAC Decitabine Sales Market Share by Region (2017-2022)

Table 44. APAC Decitabine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Decitabine Revenue Market Share by Region (2017-2022)

Table 46. APAC Decitabine Sales by Type (2017-2022) & (K Units)

Table 47. APAC Decitabine Sales Market Share by Type (2017-2022)

Table 48. APAC Decitabine Sales by Application (2017-2022) & (K Units)

Table 49. APAC Decitabine Sales Market Share by Application (2017-2022)

Table 50. Europe Decitabine Sales by Country (2017-2022) & (K Units)

Table 51. Europe Decitabine Sales Market Share by Country (2017-2022)

Table 52. Europe Decitabine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Decitabine Revenue Market Share by Country (2017-2022)

Table 54. Europe Decitabine Sales by Type (2017-2022) & (K Units)

Table 55. Europe Decitabine Sales Market Share by Type (2017-2022)

Table 56. Europe Decitabine Sales by Application (2017-2022) & (K Units)

Table 57. Europe Decitabine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Decitabine Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Decitabine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Decitabine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Decitabine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Decitabine Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Decitabine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Decitabine Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Decitabine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Decitabine

Table 67. Key Market Challenges & Risks of Decitabine

Table 68. Key Industry Trends of Decitabine

Table 69. Decitabine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Decitabine Distributors List

Table 72. Decitabine Customer List

Table 73. Global Decitabine Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Decitabine Sales Market Forecast by Region

Table 75. Global Decitabine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Decitabine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Decitabine Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Decitabine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Decitabine Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Decitabine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Decitabine Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Decitabine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Decitabine Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Decitabine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Decitabine Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Decitabine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Decitabine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Decitabine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Decitabine Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Decitabine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Decitabine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Decitabine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Johnson & Johnson Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 94. Johnson & Johnson Decitabine Product Offered

Table 95. Johnson & Johnson Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Johnson & Johnson Main Business

Table 97. Johnson & Johnson Latest Developments

Table 98. Eli Lilly and Company Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 99. Eli Lilly and Company Decitabine Product Offered

Table 100. Eli Lilly and Company Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Eli Lilly and Company Main Business

Table 102. Eli Lilly and Company Latest Developments

Table 103. Pharmachemie B.V. Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 104. Pharmachemie B.V. Decitabine Product Offered

Table 105. Pharmachemie B.V. Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Pharmachemie B.V. Main Business

Table 107. Pharmachemie B.V. Latest Developments

Table 108. Otsuka Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 109. Otsuka Pharmaceutical Decitabine Product Offered

Table 110. Otsuka Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Otsuka Pharmaceutical Main Business

Table 112. Otsuka Pharmaceutical Latest Developments

Table 113. Sandoz Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 114. Sandoz Decitabine Product Offered

Table 115. Sandoz Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Sandoz Main Business

Table 117. Sandoz Latest Developments

Table 118. Dr Reddy's Laboratories Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 119. Dr Reddy's Laboratories Decitabine Product Offered

Table 120. Dr Reddy's Laboratories Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Dr Reddy's Laboratories Main Business

Table 122. Dr Reddy's Laboratories Latest Developments

Table 123. Accord Healthcare Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 124. Accord Healthcare Decitabine Product Offered

Table 125. Accord Healthcare Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Accord Healthcare Main Business

Table 127. Accord Healthcare Latest Developments

Table 128. Sun Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 129. Sun Pharmaceutical Decitabine Product Offered

Table 130. Sun Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Sun Pharmaceutical Main Business

Table 132. Sun Pharmaceutical Latest Developments

Table 133. Cipla Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 134. Cipla Decitabine Product Offered

Table 135. Cipla Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Cipla Main Business

Table 137. Cipla Latest Developments

Table 138. Lupin Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 139. Lupin Decitabine Product Offered

Table 140. Lupin Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Lupin Main Business

Table 142. Lupin Latest Developments

Table 143. Shandong Xinshidai Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 144. Shandong Xinshidai Pharmaceutical Decitabine Product Offered

Table 145. Shandong Xinshidai Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Shandong Xinshidai Pharmaceutical Main Business

Table 147. Shandong Xinshidai Pharmaceutical Latest Developments

Table 148. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 149. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product Offered

Table 150. Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Hangzhou Zhongmei Huadong Pharmaceutical Main Business

Table 152. Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments

Table 153. ZHENGDA Tianqing Pharmaceutical Group Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 154. ZHENGDA Tianqing Pharmaceutical Group Decitabine Product Offered

Table 155. ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. ZHENGDA Tianqing Pharmaceutical Group Main Business

Table 157. ZHENGDA Tianqing Pharmaceutical Group Latest Developments

Table 158. Jiangsu Aosaikang Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 159. Jiangsu Aosaikang Pharmaceutical Decitabine Product Offered

Table 160. Jiangsu Aosaikang Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Jiangsu Aosaikang Pharmaceutical Main Business

Table 162. Jiangsu Aosaikang Pharmaceutical Latest Developments

Table 163. Jiangsu Haosen Pharmaceutical Group Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 164. Jiangsu Haosen Pharmaceutical Group Decitabine Product Offered

Table 165. Jiangsu Haosen Pharmaceutical Group Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Jiangsu Haosen Pharmaceutical Group Main Business

Table 167. Jiangsu Haosen Pharmaceutical Group Latest Developments

Table 168. Lianyungang Jierui Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 169. Lianyungang Jierui Pharmaceutical Decitabine Product Offered

Table 170. Lianyungang Jierui Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Lianyungang Jierui Pharmaceutical Main Business

Table 172. Lianyungang Jierui Pharmaceutical Latest Developments

Table 173. Qilu Pharmaceutical Hainan Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 174. Qilu Pharmaceutical Hainan Decitabine Product Offered

Table 175. Qilu Pharmaceutical Hainan Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. Qilu Pharmaceutical Hainan Main Business

Table 177. Qilu Pharmaceutical Hainan Latest Developments

Table 178. Lianyungang Runzhong Pharmaceutical Basic Information, Decitabine Manufacturing Base, Sales Area and Its Competitors

Table 179. Lianyungang Runzhong Pharmaceutical Decitabine Product Offered

Table 180. Lianyungang Runzhong Pharmaceutical Decitabine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 181. Lianyungang Runzhong Pharmaceutical Main Business

Table 182. Lianyungang Runzhong Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Decitabine

Figure 2. Decitabine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Decitabine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Decitabine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Decitabine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 10 Mg Dosage Forms

Figure 10. Product Picture of 15 Mg Dosage Forms

Figure 11. Product Picture of 25 Mg Dosage Forms

Figure 12. Global Decitabine Sales Market Share by Type in 2021

Figure 13. Global Decitabine Revenue Market Share by Type (2017-2022)

Figure 14. Decitabine Consumed in Primary MDS

Figure 15. Global Decitabine Market: Primary MDS (2017-2022) & (K Units)

Figure 16. Decitabine Consumed in Secondary MDS

Figure 17. Global Decitabine Market: Secondary MDS (2017-2022) & (K Units)

Figure 18. Global Decitabine Sales Market Share by Application (2017-2022)

Figure 19. Global Decitabine Revenue Market Share by Application in 2021

Figure 20. Decitabine Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Decitabine Revenue Market Share by Company in 2021

Figure 22. Global Decitabine Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Decitabine Revenue Market Share by Geographic Region in 2021

Figure 24. Global Decitabine Sales Market Share by Region (2017-2022)

Figure 25. Global Decitabine Revenue Market Share by Country/Region in 2021

Figure 26. Americas Decitabine Sales 2017-2022 (K Units)

Figure 27. Americas Decitabine Revenue 2017-2022 ($ Millions)

Figure 28. APAC Decitabine Sales 2017-2022 (K Units)

Figure 29. APAC Decitabine Revenue 2017-2022 ($ Millions)

Figure 30. Europe Decitabine Sales 2017-2022 (K Units)

Figure 31. Europe Decitabine Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Decitabine Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Decitabine Revenue 2017-2022 ($ Millions)

Figure 34. Americas Decitabine Sales Market Share by Country in 2021

Figure 35. Americas Decitabine Revenue Market Share by Country in 2021

Figure 36. United States Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Decitabine Sales Market Share by Region in 2021

Figure 41. APAC Decitabine Revenue Market Share by Regions in 2021

Figure 42. China Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Decitabine Sales Market Share by Country in 2021

Figure 49. Europe Decitabine Revenue Market Share by Country in 2021

Figure 50. Germany Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Decitabine Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Decitabine Revenue Market Share by Country in 2021

Figure 57. Egypt Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Decitabine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Decitabine in 2021

Figure 63. Manufacturing Process Analysis of Decitabine

Figure 64. Industry Chain Structure of Decitabine

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390